Blar i forfatter "Møller, Bjørn"

Viser treff 1-4 av 4

    • Concordance between clinical and pathology TNM-staging in lung cancer 

      Solberg, Steinar; Nilssen, Yngvar; Brustugun, Odd Terje; Haram, Per Magnus; Helland, Åslaug; Møller, Bjørn; Strand, Trond-Eirik; Wahl, Sissel Gyrid Freim; Fjellbirkeland, Lars (Journal article; Tidsskriftartikkel; Peer reviewed, 2022-07-25)
      Objectives: A prerequisite for utilizing the tumour, lymph-nodes, and metastases (TNM) for the staging of lung cancer patients is a high quality of the reported data on which the staging is based. The aim of this study was to investigate the concordance between the clinical, cTNM and the pathology, pTNM staging for lung cancer, version 8 as reported to the Cancer Registry of Norway (CRN).<p> < ...

    • Ethnic differences in the incidence of cancer in Norway 

      Vik, Kirsti Lund; Qureshi, Samera Azeem; Møller, Bjørn; Weiderpass, Elisabete; Deapen, Dennis; Kumar, Bernadette. N; Ursin, Giske (Journal article; Tidsskriftartikkel; Peer reviewed, 2017-01-24)
      Traditionally there have been differences in cancer incidence across geographic regions. When immigrants have moved from low-income to high-income countries, their incidence have changed as they have adapted to the lifestyle in the new host country. Given worldwide changes in lifestyle factors over time, we decided to examine cancer incidence in immigrant groups in Norway, a country with a recent ...

    • Treatment and survival of patients with pancreatic ductal adenocarcinoma: 15-year national cohort 

      Nymo, Linn Såve; Lassen, Kristoffer; Myklebust, Tor Åge; Møller, Bjørn (Journal article; Tidsskriftartikkel; Peer reviewed, 2022-03-08)
      Background - Improvement in survival from pancreatic ductal adenocarcinoma (PDAC) has been reported in trial settings but is less explored in unselected cohorts. The aim of this study was to assess trends in provision of treatments and survival in Norway over a 15-year period following the implementation of hepato-pancreato-biliary (HPB) multidisciplinary teams, centralization of surgery, and ...

    • Utvikling av indikatorer på NCD området knyttet til rapportering for den globale og nasjonale NCD strategien 

      Ariansen, Inger; Nystad, Wenche; Graff-Iversen, Sidsel; Gulseth, Hanne Løvdal; Meyer, Haakon E; Brunborg, Geir Scott; Vedøy, Tord Finne; Vollset, Stein Emil; Reneflot, Anne; Nerhus, Kjersti Andersen; Henrichsen, Svein Høegh; Huseby, Beate Margrethe; Nylenna, Astrid; Anderssen, Sigmund Alfred; Ekelund, Ulf; Krokstad, Steinar; Møller, Bjørn; Weiderpass, Elisabete; Tell, Grethe S.; Gram, Inger Torhild; Grimsgaard, Sameline; Njølstad, Inger; Bakke, Per; Husebø, Gunnar (Research report; Forskningsrapport, 2017-04)
      Norge har sluttet seg til WHO sitt mål om 25% reduksjon 2010 til 2025 i for tidlig død som følge av de fire ikke-smittsomme sykdommene (noncommunicale disease, NCD); kreft, hjerte- og karsykdom, diabetes og kronisk lungesykdom. Bakgrunnen er at disse fire sykdomsgruppene langt på vei kan forebygges ved å redusere de fire felles risikofaktorene røyking, usunn kost, stillesitting og skadelig bruk ...